FCR, IBRUTINIB, VENETOCLAX what next...Stem Ce... - CLL Support

CLL Support

22,369 members38,477 posts

FCR, IBRUTINIB, VENETOCLAX what next...Stem Cell or CAR-T

NMMP profile image
NMMP
19 Replies

Happy Easter everyone!

So on this journey since Dec. 2010 and we can't seem to hit that remission "sweet spot" that we read about in the stats or trials - is it us or just the reality of how everyone's battle is unique in the world of CLL?

We started V at the end of Feb. 2017 (as I posted our experience back in Feb/March) the introduction was scary and our toughest challenge yet. 2 months later, my husband has certainly tolerated V and showing great signs of improvement everyday - however we know this is temporary. Mark's CLL Is very aggressive and we were 1st hand witnesses to its power. The biggest lesson that came out of our last relapse was how quick this disease can progress. We started failing on ibrutinib in Nov. 2016 and by Feb. 2017 the progression was like watching Usain Bolt running the 100m in Rio - moving at its own pace and leaving everything and everyone behind.

So what next?? Mark always states he views his CLL as a chess game and he likes to be 2 moves ahead of his opponent - but at this point there really is only 1 move left Stem Cell (which we find terrifying) or CART-T (which has really made huge strides since we 1st read about it in 2011). Our health professionals are all guiding us on the Stem Cell route where we are thinking we need to explore CAR-T but every time we mention CAR-T the response is very negative and I feel like it is a "dirty word". We live in Canada were there has not been a lot of research/progress on CAR-T.

My question is what would you do and can this great CLL family offer their insight and knowledge to assist us in our next chess move???

NMMP

Written by
NMMP profile image
NMMP
To view profiles and participate in discussions please or .
Read more about...
19 Replies
newyork8 profile image
newyork8

Perhaps a combination therapy using multiple drugs should be considered?

Jm954 profile image
Jm954Administrator

Hiya, I'm sorry to hear that your husband's CLL is proving so difficult to manage.

My understanding of CAR-T therapy is that it is most useful in eliminating residual disease where a reasonable response has already been achieved with another treatment. If there were too many CLL cells present the cytokine release syndrome could be fatal. I had a look for CAR-T clinical trials for CLL in Canada but didn't find anything although there was one for ALL.

Venetoclax has given some people MRD negative CR's so I'm going to keep my fingers crossed that it works it's magic for your husband, at least long enough for the CAR-T or another wonder drug to become available. As your husband says, just need to stay ahead of the CLL!

Take care both and best of luck.

NMMP profile image
NMMP in reply to Jm954

Hi Jm494,

Thank you for the support and advice - as we understand V should certainly help with getting a decent MRD reading and there have been a few studies where Venetoclax/Rituximab combination gets you even further MRD.

We are currently in discussion with our Hematologist about the Venetoclax/Rituximab combo but it has not been approved in our part of the country but trying to see what we can do about it. We are fortunate that our Haematologist is also willing to "break a few rules" when he feels it is the best solution.

Take care and again thank you,

NMMP

AussieNeil profile image
AussieNeilAdministrator in reply to NMMP

Dr Philip Thompson's update on CAR-T therapy in CLL a year ago:

patientpower.info/video/an-...

I expect that there's only a slim chance of gaining access to a CAR- T trial in Canada - but you seem to have a helpful specialist assisting you to find a suitable next step...

NMMP profile image
NMMP in reply to AussieNeil

Thanks AussieNeil - Canada always seems to be 1 to 2 steps behnind the US.

NNMP

maggiesgrandmom profile image
maggiesgrandmom

Hi NMMP, Dr. Mato from Penn has some new drugs coming up. He will be speaking this Thursday night with the CLL society. Maybe you will be able to catch the video on the CLL Society website. Dr. Koffman just posted about it.

NMMP profile image
NMMP

Hi Janicelee - thanks for the heads up, will definitely take a look.

Appreciate the support.

Take care,

NMMP

beanlake14 profile image
beanlake14 in reply to NMMP

When I relapse, the doctors at MD Anderson are putting me on a combo of ibrutinib and venetoclax. So, I have not tried this yet, but that is the plan. Dr. Thompson does not like mono therapies, so we will see. I pray that venetoclax gets you some time. My dear friend who is 17p got four years on it before she had to switch to something else. I will find out the trial she is in now which is working well for her.

NMMP profile image
NMMP in reply to beanlake14

Thank you beanlake14 - 4 years on V with 17p is impressive, and something to hope for. If possible would appreciate the trial your friend is on.

Wishing you luck and success on your combo of ibrutinib/venetoclax.

Take care,

NMMP

beanlake14 profile image
beanlake14 in reply to NMMP

TGR 1202 plus TGR 1101 Ubilituximab (anti cd20 like rituxan but they think better). Phase three trial.

NMMP profile image
NMMP in reply to beanlake14

Thanks again

bronx77 profile image
bronx77

Hi sorry things are not going to well

As I understand it CAR-T for Cll has not made it to clinical trials yet

It works by identifying the exact protein that causes your mutations and then the protein that kills off the mutation

The patients own cells are then exposed to that protein to reprogram them to attack the mutations

And given back to the patient

It is very personal to the patient

As already mentioned it's only available for ALL at the moment and most people are going to SEATTLE for treatment

Wishing you well for the future

canadagoose profile image
canadagoose in reply to bronx77

Actually CAR-T works better for CLL than ALL and AML and is being used in Seattle, Penn, NIH, MD Anderson, and some of the other centers.

nkferg profile image
nkferg

There are several trials going on in the US:

clinicaltrials.gov/ct2/resu...

The main thing is if you can travel outside of Canada and afford the treatment. If costs of treatment are covered, travel and lodging might not. If you can, get with a CLL specialist and see if one would possibly benefit you. They seem very specific, so one might fit better than others. There are only 6 actively recruiting.

If you are unable to travel, I guess I would try and get mind and body behind the stem cell treatment. Best of luck in your decision and I hope you have plenty of time to make the best choice for you and your family.

There are actually more CAR-T trials going on in China than in the US......

nkferg profile image
nkferg in reply to nkferg

this is of course if other drug options are not available.

Hoffy profile image
Hoffy

Glad to hear he is doing better. It seems if you can get on some type a combo with V that would be helpful. Some papers have said it works better in a combo arrangement.

Be well.

NMMP profile image
NMMP in reply to Hoffy

Thanks Hoffy - yes, he certainly is doing much better but still trying to balance his blood work. The neutrophils are a real balancing act with V - we never had this issue on ibrutinib.

The combo theme seems to be the trick moving forward.

Take care,

NMMP

nkferg profile image
nkferg in reply to NMMP

I am on V-I, WBC went below normal last week. I hope they stabilize and it is not an issue. From 169 down to 3.8 in 3 months.

NMMP profile image
NMMP in reply to nkferg

Fingers crossed that they do stabilize - best of luck.

NMMP

You may also like...

POST 6 CAR-T cell therapy

was to be listed for admission to proceed with CAR-T cell therapy, despite minimal improvement in...

CAR T for richter transformation

Hi, my husband has cll/RT and he is going to have car T cell next week, I would like to meet anybody

Venetoclax/Ibrutinib update

wanted to follow up with everyone. I started the V&I clinical trial Oct 2017. When i started my...

Still on hold for stem cell transplant

good, that his cancer cells had been reduced sufficiently to proceed with transplant. After our...

Medicare will begin nationwide coverage of CAR T-cell therapy

has approved chimeric antigen receptor T-cell, or CAR T-cell, therapy to treat some specific...